A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and leukemia group B (CALGB) 8931

被引:26
作者
Herndon, JE
Fleishman, S
Kosty, MP
Green, MR
机构
[1] LONG ISL JEWISH MED CTR, NEW HYDE PK, NY 11042 USA
[2] SCRIPPS CLIN, LA JOLLA, CA USA
[3] UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92103 USA
来源
CONTROLLED CLINICAL TRIALS | 1997年 / 18卷 / 04期
关键词
quality of life; clinical trial; non-small cell lung cancer; hydrazine sulfate;
D O I
10.1016/0197-2456(96)00116-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A quality of life (QOL) endpoint supplemented standard clinical endpoints of survival, tumor response, and toxicity in a double-blind study conducted by the Cancer and Leukemia Group B (CALGB) where 291 patients with advanced non-small cell lung cancer (NSCLC) were randomly assigned to receive cisplatin/vinblastine with either hydrazine sulfate (HS) or placebo. The difficulties associated with the analysis of the longitudinal QOL data, and the contributions that the QOL endpoint made to the understanding of treatment differences, will be the focus of this paper. (C) Elsevier Science Inc. 1997.
引用
收藏
页码:286 / 300
页数:15
相关论文
共 24 条
[1]  
Aaronson N K, 1988, Recent Results Cancer Res, V111, P231
[2]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[3]  
Aaronson NK, 1991, EFFECT CANC QUALITY, P185
[4]  
*AM CANC SOC, 1996, CANC FACTS FIG 1996
[5]  
BERGMAN C, EUR J CANCER, V30, P635
[6]   THE DUKE-UNC FUNCTIONAL SOCIAL SUPPORT QUESTIONNAIRE - MEASUREMENT OF SOCIAL SUPPORT IN FAMILY MEDICINE PATIENTS [J].
BROADHEAD, WE ;
GEHLBACH, SH ;
DEGRUY, FV ;
KAPLAN, BH .
MEDICAL CARE, 1988, 26 (07) :709-723
[7]   HYDRAZINE SULFATE INFLUENCE ON NUTRITIONAL-STATUS AND SURVIVAL IN NON-SMALL-CELL LUNG-CANCER [J].
CHLEBOWSKI, RT ;
BULCAVAGE, L ;
GROSVENOR, M ;
OKTAY, E ;
BLOCK, JB ;
CHLEBOWSKI, JS ;
ALI, I ;
ELASHOFF, R .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :9-15
[8]  
CHLEBOWSKI RT, 1987, CANCER, V59, P406, DOI 10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO
[9]  
2-W
[10]  
Diggle P., 2002, Analysis of longitudinal data